Agenda Details

Learn more about sessions and presentations at the 26th Annual Meeting

Detailed Program

Use of Rat Data to Support an IND for a Rare Disease Trial (NGLY1)

Becky Schweighardt, PhD. Grace Science, LLC, Menlo Park, CA

Disclosures: B. Schweighardt: 1; Commercial Interest i.e. Company X; Grace Science, LLC. 1; What was received? i.e. Honorarium; salary and stock options. 1; For what role? i.e. Speaker; employee and stock holder.

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.